[go: up one dir, main page]

MX2018000166A - Metodos para una mejor administración de agentes activos a tumores. - Google Patents

Metodos para una mejor administración de agentes activos a tumores.

Info

Publication number
MX2018000166A
MX2018000166A MX2018000166A MX2018000166A MX2018000166A MX 2018000166 A MX2018000166 A MX 2018000166A MX 2018000166 A MX2018000166 A MX 2018000166A MX 2018000166 A MX2018000166 A MX 2018000166A MX 2018000166 A MX2018000166 A MX 2018000166A
Authority
MX
Mexico
Prior art keywords
methods
tumors
active agents
better delivery
agents
Prior art date
Application number
MX2018000166A
Other languages
English (en)
Inventor
Frederick Ross Russell
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of MX2018000166A publication Critical patent/MX2018000166A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

La presente invención se refiere a la administración de agentes a través de la piel. Los métodos para administrar agentes tales como agentes bioactivos se contemplan en la presente invención. Específicamente, se describen métodos para la administración dirigida de agentes a una o más áreas de la epidermis y, de esta manera, a uno o más tumores de cáncer.
MX2018000166A 2015-07-24 2016-07-22 Metodos para una mejor administración de agentes activos a tumores. MX2018000166A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562196578P 2015-07-24 2015-07-24
US201562196570P 2015-07-24 2015-07-24
PCT/US2016/043623 WO2017019526A2 (en) 2015-07-24 2016-07-22 Methods for better delivery of active agents to tumors

Publications (1)

Publication Number Publication Date
MX2018000166A true MX2018000166A (es) 2018-03-26

Family

ID=57885141

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018000166A MX2018000166A (es) 2015-07-24 2016-07-22 Metodos para una mejor administración de agentes activos a tumores.
MX2022014277A MX2022014277A (es) 2015-07-24 2018-01-08 Metodos para una mejor administracion de agentes activos a tumores.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022014277A MX2022014277A (es) 2015-07-24 2018-01-08 Metodos para una mejor administracion de agentes activos a tumores.

Country Status (15)

Country Link
US (3) US10806913B2 (es)
EP (2) EP3325080B1 (es)
JP (1) JP7082041B2 (es)
KR (1) KR20180035209A (es)
CN (2) CN118902979A (es)
AU (3) AU2016297823B2 (es)
BR (1) BR112018001292A2 (es)
CA (1) CA2991455C (es)
DK (1) DK3325080T3 (es)
ES (1) ES2891523T3 (es)
HU (1) HUE056410T2 (es)
MX (2) MX2018000166A (es)
PL (1) PL3325080T3 (es)
RU (1) RU2719943C2 (es)
WO (1) WO2017019526A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107949418B (zh) * 2015-07-24 2024-07-02 索伦托治疗有限公司 用于活性剂的淋巴递送的方法
PL3325080T3 (pl) * 2015-07-24 2022-01-24 Sorrento Therapeutics, Inc. Sposoby lepszego dostarczania środków czynnych do guzów
IL301683B2 (en) 2017-05-17 2025-02-01 Massachusetts Inst Technology Self-healing systems and related components and methods
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
WO2019012382A1 (en) 2017-07-10 2019-01-17 Basf Se MIXTURES COMPRISING A UREASE INHIBITOR (UI) AND A NITRIFICATION INHIBITOR SUCH AS 2- (3,4-DIMETHYL-1H-PYRAZOL-1-YL) SUCCINIC ACID (DMPSA) OR 3,4-DIMETHYL PYRAZOLIUM GLYCOLATE (DMPG)
EP3793667A1 (en) 2018-05-17 2021-03-24 Massachusetts Institute of Technology Systems for electrical stimulation
WO2019232265A1 (en) * 2018-05-31 2019-12-05 Sorrento Therapeutics, Inc. Drug delivery methods targeting the lymphatic system
CN112752590A (zh) 2018-09-24 2021-05-04 欧莱雅 包含用于皮肤原位反应的微针的装置
EP3856321A1 (en) * 2018-09-24 2021-08-04 L'oreal Device comprising microneedles for skin-coloring
KR20220110273A (ko) * 2019-12-05 2022-08-05 소렌토 쎄라퓨틱스, 인코포레이티드 항-pd-1 또는 항-pd-l1 치료제를 림프 전달 장치를 통해 투여하여 암을 치료하는 방법
CN117813128A (zh) 2021-01-22 2024-04-02 索伦托药业有限公司 用于微升级淋巴递送冠状病毒疫苗的装置
WO2022192594A2 (en) 2021-03-11 2022-09-15 Sorrento Therapeutics, Inc. Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
CA3221925A1 (en) 2021-06-09 2022-12-15 Sorrento Therapeutics, Inc. Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic microneedle delivery device
US20250120905A1 (en) 2021-08-18 2025-04-17 Vivasor, Inc Therapeutic agents targeting the lymphatic system
WO2025129128A1 (en) 2023-12-15 2025-06-19 Vivasor, Inc. Compositions and methods for non-viral delivery of therapeutic compounds

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
PL201222B1 (pl) 2000-06-01 2009-03-31 Watson Pharmaceuticals Preparat transdermalny lazoksyfenu, urządzenie do podawania lazoksyfenu, oraz zastosowanie lazoksyfenu
JP4383168B2 (ja) * 2001-09-12 2009-12-16 ベクトン・ディキンソン・アンド・カンパニー マイクロ針投与デバイスおよび薬物投与デバイス
US20050163711A1 (en) * 2003-06-13 2005-07-28 Becton, Dickinson And Company, Inc. Intra-dermal delivery of biologically active agents
MXPA06002159A (es) 2003-08-26 2006-05-22 Becton Dickinson Co Metodos para la administracion intradermica de agentes terapeuticos.
CA2580329C (en) * 2004-09-13 2015-01-06 Chrono Therapeutics Inc. Biosynchronous transdermal drug delivery
US20070088414A1 (en) * 2005-05-25 2007-04-19 Campbell Robert L Particulate formulations for intradermal delivery of biologically active agents
WO2006138719A2 (en) * 2005-06-17 2006-12-28 Georgia Tech Research Corporation Coated microstructures and method of manufacture thereof
US8197435B2 (en) 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
EP2100850A1 (en) * 2008-03-11 2009-09-16 Stichting Voor De Technische Wetenschappen Microneedle array and a method for manufacturing microneedles
US8715736B2 (en) * 2009-04-30 2014-05-06 Florida Agricultural And Mechanical University Nanoparticle formulations for skin delivery
CN101829394B (zh) * 2010-04-27 2012-08-22 上海交通大学 台阶微针阵列的制备方法
PT2563450T (pt) 2010-04-28 2017-08-28 Kimberly Clark Co Dispositivo para entrega de medicação para a artrite reumatóide
US10245421B2 (en) 2010-04-28 2019-04-02 Sorrento Therapeutics, Inc. Nanopatterned medical device with enhanced cellular interaction
CA2796965C (en) 2010-04-28 2019-04-16 Kimberly-Clark Worldwide, Inc. Method for increasing permeability of an epithelial barrier
RU2585138C2 (ru) 2010-04-28 2016-05-27 Кимберли-Кларк Ворлдвайд, Инк. Медицинские устройства для доставки кирнк
US20120187814A1 (en) 2011-01-25 2012-07-26 Fryling Nicholas A Furniture System and a Frame Assembly for a Furniture System
US20120245445A1 (en) * 2011-03-21 2012-09-27 Michael Darryl Black Glucose Monitoring System
JP6219832B2 (ja) * 2011-10-17 2017-10-25 マサチューセッツ インスティテュート オブ テクノロジー 細胞内送達
CN104039382B (zh) * 2011-10-27 2018-01-12 金伯利-克拉克环球有限公司 高粘度生物活性剂的经皮递送
KR101575039B1 (ko) 2012-07-19 2015-12-07 (주)아모레퍼시픽 노즐 장치 및 이를 포함하는 최소 침습형 주입 장치
CN104661695B (zh) * 2012-09-13 2019-02-15 亚夫拉罕·阿米尔 用于皮肤改善的递送装置和方法
BR112015006176B1 (pt) * 2012-09-21 2023-04-18 Intensity Therapeutics, Inc Uso de um agente terapêutico e de um agente de intensificação de permeação intracelular
CN103157178B (zh) * 2013-02-05 2014-12-31 北京化工大学 精确控制微针插入长度的印章式工具
EP2961469A4 (en) 2013-02-28 2016-10-26 Kimberly Clark Co DEVICE FOR DELIVERY OF MEDICAMENT
BR112015020328B1 (pt) 2013-02-28 2022-05-31 Sorrento Therapeutics, Inc Dispositivo de aplicação transdérmica de droga
AU2014270014A1 (en) 2013-05-23 2015-12-17 Kimberly-Clark Worldwide, Inc. Microneedles with improved open channel cross-sectional geometries
US10376674B2 (en) * 2014-09-15 2019-08-13 Ethicon, Inc. System and method for targeted delivery of therapeutic agents to tissue
CN107949418B (zh) * 2015-07-24 2024-07-02 索伦托治疗有限公司 用于活性剂的淋巴递送的方法
PL3325080T3 (pl) * 2015-07-24 2022-01-24 Sorrento Therapeutics, Inc. Sposoby lepszego dostarczania środków czynnych do guzów

Also Published As

Publication number Publication date
WO2017019526A2 (en) 2017-02-02
ES2891523T3 (es) 2022-01-28
CN107921248A (zh) 2018-04-17
EP3325080A4 (en) 2019-04-17
HUE056410T2 (hu) 2022-02-28
AU2016297823B2 (en) 2020-10-22
MX2022014277A (es) 2022-12-07
CA2991455C (en) 2023-10-10
PL3325080T3 (pl) 2022-01-24
JP7082041B2 (ja) 2022-06-07
RU2018104102A3 (es) 2019-11-06
CN118902979A (zh) 2024-11-08
US10806913B2 (en) 2020-10-20
EP3925599A1 (en) 2021-12-22
AU2022275397A1 (en) 2023-01-05
CA2991455A1 (en) 2017-02-02
JP2018521755A (ja) 2018-08-09
EP3325080B1 (en) 2021-09-01
KR20180035209A (ko) 2018-04-05
DK3325080T3 (da) 2021-10-04
RU2719943C2 (ru) 2020-04-23
AU2021200146B2 (en) 2022-08-25
AU2021200146A1 (en) 2021-03-18
AU2016297823A1 (en) 2018-02-15
RU2018104102A (ru) 2019-08-27
US20180193624A1 (en) 2018-07-12
EP3325080A2 (en) 2018-05-30
US20210052871A1 (en) 2021-02-25
US20240238570A1 (en) 2024-07-18
BR112018001292A2 (pt) 2018-09-11

Similar Documents

Publication Publication Date Title
MX2018000166A (es) Metodos para una mejor administración de agentes activos a tumores.
ECSP24031979A (es) Compuestos terapéuticamente activos y sus métodos de uso
CL2018001152A1 (es) Composiciones y métodos para el tratamiento del cáncer
MX373187B (es) Terapia de combinación para tratar cáncer.
ECSP15026557A (es) Compuestos y sus métodos de empleo
PH12016501139B1 (en) Bicyclic heterocycle compounds and their uses in therapy
MX376329B (es) Composiciones farmaceuticas de compuestos terapeuticamente activos y sus metodos de uso.
MX2018001723A (es) Conjugados farmaco-multiligando y usos de los mismos.
SV2017005489A (es) Terapias de combinación para el tratamiento de cánceres
MX2019008085A (es) Antagonistas de activina-actrii y usos para tratar transtornos oseos y otros.
DOP2015000189A (es) Inhibidores quinazolínicos de formas mutadas activantes del receptor del factor de crecimiento epidérmico
MY188139A (en) Sodium channel modulators for the treatment of pain
MA40437A (fr) Méthodes de traitement du cancer faisant appel à des inhibiteurs de tigit et à des agents anticancéreux
MX2017017079A (es) Sistema de administracion dirigida de principio activo celular.
DOP2017000035A (es) Inhibidores de la proteina quinasa c y metodos de su uso
CR20120508A (es) PROTEÍNA DE FUSIÓN ROBO1-Fc Y SU UTILIZACIÓN EN EL TRATAMIENTO DE TUMORES
EA201591924A1 (ru) Способы лечения злокачественной опухоли с использованием комбинированной терапии с коферментом q10
MX385762B (es) Métodos para el control transcripcional objetivo en regiones del super mejorador.
MX2022014634A (es) Metodos para la administracion linfatica de agentes activos.
EA201591925A1 (ru) Терапевтические композиции и их применение
PH12015502616A1 (en) Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer
MX2016009284A (es) Construcciones dirigidas a receptor y sus usos.
MX383944B (es) Composiciones para el cuidado personal.
SG11201610947UA (en) Pharmaceutical composition comprising recombinant hemoglobin protein or subunit-based therapeutic agent for cancer targeting treatment
MX2018000052A (es) Composiciones y métodos para la terapia combinada con virus del dengue y celulas dendríticas.